Medical AI Future: Sustainable Reimbursement Strategies

By HEOR Staff Writer

May 6, 2024

Sustainable Reimbursement for Medical AI

Introduction

Artificial Intelligence (AI) in medicine has the potential to significantly enhance patient care, yet its widespread adoption is very dependent on sustainable reimbursement models. In a recent article, authors examine how fee-for-service (FFS) and value-based care (VBC) can facilitate the scaling of medical AI, and they propose strategies to align stakeholder interests.

The Challenge of Medical AI Reimbursement

Medical AI’s promise to enhance patient outcomes faces a significant obstacle: achieving sustainable reimbursement. Although the U.S. healthcare system offers a blueprint for this process, the path to reimbursement is filled with multiple complexities, necessitating the collaboration of diverse stakeholders.

Fee-for-Service: A Traditional Approach

FFS remains a prevalent model where medical AI services are billed similarly to other medical interventions. While this model offers transparency and can provide financial sustainability, it is not without risks, such as potential over utilisation and exacerbation of health disparities.

The Shift to Value-Based Care

VBC is reshaping the reimbursement landscape by focusing on patient outcomes and efficiency. This model accounts for a substantial portion of U.S. healthcare spending and offers fewer regulatory constraints. However, the real-world impact of VBC on cost and quality of care remains mixed.

Emerging Models and Real-World Cases

New reimbursement models are emerging, such as revenue-sharing approaches akin to the Medicare Part B drug payment system. Real-world cases, like autonomous AI for diabetic eye examinations, demonstrate how FFS and VBC can be effectively leveraged for reimbursement.

Accelerating Adoption Through Strategic Reimbursement

To expedite the adoption of medical AI, creators must navigate the reimbursement landscape effectively. This may involve pursuing FFS pathways, such as establishing a Current Procedural Terminology (CPT) code, or integrating into existing VBC frameworks like Merit-Based Incentive Payment Systems/ Healthcare Effectiveness Data and Information Set (MIPS/HEDIS).

Conclusion

The journey towards sustainable reimbursement for medical AI is complex, yet essential for its successful integration into healthcare. By understanding and utilising current FFS and VBC models, stakeholders can ensure that medical AI reaches its full potential in improving patient outcomes.

Reference url

Recent Posts

GLP-1 Medication Access
Expanded GLP-1 Medication Access Through Formulary Updates

By HEOR Staff Writer

May 29, 2026

CVS Caremark's latest formulary changes are poised to strengthen GLP-1 Medication Access for commercial plan members by restoring coverage for select weight-management therapies. Effective October 1, 2026, Zepbound returns as a preferred option on template formularies for sponsors that elect c...
comparative effectiveness research
Integration of Comparative Effectiveness Research into Drug Pricing Frameworks

By João L. Carapinha

May 29, 2026

Contemporary comparative effectiveness research plays a vital role in supporting federal and state drug pricing programs by highlighting real-world benefits, yet persistent challenges and unclear guidance continue to limit its integration. Core principles of evidence evaluation, research question...
European pharmacists preparation
European Pharmacists Preparation for Health Crisis Response

By João L. Carapinha

May 29, 2026

European pharmacists preparation ensures that community networks remain operational during health crises, enabling continuous patient care amid pandemics and infrastructure failures. The recently published PGEU position paper outlines seven priorities that integrate pharmacies into governance str...